Expression of cytokines and their receptors by psoriatic fibroblasts I. Altered IL-6 synthesis

Cytokine

Volumn 8, Issue 1, 1996, Pages 70-79

  Debets, Reno ^a   Hegmans, Joost P J J ^a   Deleuran, Mette ^b   'T Hooft, Sinka ^b   Benner, Robbert ^b   Prens, Errol P ^a  

^a ERASMUS UNIVERSITY ROTTERDAM   (Netherlands)

^b AARHUS UNIVERSITY HOSPITAL   (Denmark)

Author keywords

Fibroblast; IL 6; mRNA; Psoriasis; Serum

Indexed keywords

CYCLOHEXIMIDE; CYTOKINE; CYTOKINE RECEPTOR; GROWTH FACTOR; INTERLEUKIN 1; INTERLEUKIN 6; INTERLEUKIN 8; MESSENGER RNA; REPRESSOR PROTEIN; TUMOR NECROSIS FACTOR ALPHA;

ARTICLE; BIOASSAY; CLINICAL ARTICLE; CONTROLLED STUDY; CULTURE MEDIUM; ENZYME LINKED IMMUNOSORBENT ASSAY; FETAL CALF SERUM; FIBROBLAST CULTURE; HUMAN; HUMAN CELL; NORTHERN BLOTTING; PRIORITY JOURNAL; PROTEIN SYNTHESIS; PSORIASIS; SERUM; SKIN FIBROBLAST;

EID: 0029880655     PISSN: 10434666     EISSN: None     Source Type: Journal    
DOI: 10.1006/cyto.1996.0010     Document Type: Article

References (62)

1. Bos JD (1988) The pathomechanisms of psoriasis; the skin immune system and cyclosporine (review). Br J Dermatol 118:141-155.
2. Christophers E, Schubert C (1986) Psoriasis. In Thody AJ, Friedmann PS (eds) Scientific basis of dermatology (a physiological approach), Churchill Livingstone Publisher, London, pp 151-174.
3. Krueger GG, Manning DD, Malouf J, Ogden B (1975)Long-term maintenance of psoriatic human skin on congenitally athymic (nude) mice. J Invest Dermatol 64:307-312.
4. Fraki JE, Briggaman RA, Lazarus GS (1983) Transplantation of psoriatic skin onto nude mouse. J Invest Dermatol 80:31S-35S.
5. Baden HP, Kubilus J, Macdonald MJ (1981) Normal and psoriatic keratinocytes and fibroblasts compared in culture. J Invest Dermatol 76:53-55.
6. Karasek MA (1972) Dermal factors affecting epidermal cells in vitro. J Invest Dermatol 59:99-101.
7. Saiag P, Coulomb B, Lebreton C, Bell E, Dubertret L (1985) Psoriatic fibroblasts induce hyperproliferation of normal keratinocytes in a skin equivalent model in vitro. Science 230:669-672.
8. Priestley GC, Lord R (1990) Fibroblast-keratinocyte interactions in psoriasis: failure of psoriatic fibroblasts to stimulate keratinocyte proliferation in vitro. Br J Dermatol 123:467-472.
9. Saiag P, Coulomb B, Rowland-Payne CM, Dubertret L, Touraine R (1986) Lasers, dermal fibroblasts and psoriasis. Br J Dermatol 115:744-745.
10. Mauviel A, Temime M, Charron D, Loyau G, Pujol J-P (1991) Induction of interleukin-1β production in human dermal fibroblasts by interleukin-1α and tumor necrosis factor-α. Involvement of protein kinase-dependent and adenylate cyclase-dependent regulatory pathways. J Cell Biochem 47:174-183.
11. Van Damme J, Cayphas S, Opdenakker G, Billiau A, Van Snick J (1987) Interleukin 1 and poly(rI) poly(rC) induce production of a hybridoma growth factor by human fibroblasts. Eur J Immunol 17:1-7.
12. Larsen CG, Anderson AO, Oppenheim JJ, Matsushima K (1989) Production of interleukin-8 by human dermal fibroblasts and keratinocytes in response to interleukin-1 or tumour necrosis factor. Immunology 68:31-36.
13. Ristow HJ (1987) A major factor contributing to epidermal proliferation in inflammatory skin diseases appears to be interleukin 1 or a related protein. Proc Natl Acad Sci USA 84:1940-1944.
14. Grossman RM, Krueger J, Yourish D, Granelli-Piperno A, Murphy DP, May LT, Kupper TS, Sehgal PB, Gottlieb AB (1989) Interleukin 6 is expressed in high levels in psoriatic skin and stimulates proliferation of cultured human keratinocytes. Proc Natl Acad Sci USA 86:6367-6371.
15. Tuschil A, Lam C, Halsberger A, Lindley I (1992) Interleukin-8 stimulates calcium transients and promotes epidermal cell proliferation. J Invest Dermatol 99:294-298.
16. Espinoza LR, Espinoza CG, Cuéllar ML, Scopelitis E, Silveira LH, Grotendorst GR (1994) Fibroblast function in psoriatic arthritis. II. Increased expression of β platelet derived growth factor receptors and increased production of growth factor and cytokines. J Rheumatol 21:1507-1514.
17. Prens EP, Benne K, Van Damme J, Bakkus M, Brakel K, Benner R, Van Joost T (1990) Interleukin 1 and interleukin 6 in psoriasis. J Invest Dermatol 95:1218-1248.
18. Neuner P, Urbanski A, Trautinger F, Möller A, Kirnbauer R, Kapp A, Schopf E, Schwarz T, Luger TA (1991) Increased IL-6 production by monocytes and keratinocytes in patients with psoriasis. J Invest Dermatol 97:27-33.
19. Gearing AJH, Fincham NJ, Bird CR, Wadhwa M, Meager A, Cartwright JE, Camp RDR (1990) Cytokines in skin lesions of psoriasis. Cytokine 2:68-75.
20. Gillitzer R, Berger R, Mielke V, Muller C, Wolff K, Stingl G (1991) Upper keratinocytes of psoriatic lesions express high levels of NAP-1 /IL-8 mRNA in situ. J Invest Dermatol 97:73-79.
21. Elder JT, Sartor CI, Boman DK, Benrazavi S, Fisher GJ, Pittelkow MR (1992) Interleukin-6 in psoriasis: expression and mitogenicity studies. Arch Dermatol Res 284:324-332.
22. May LT, Santhanam U, Sehgal PB (1991) On the multimeric nature of natural human intereukin-6. J Biol Chem 266:9950-9955.
23. Aarden LA, De Groot ER, Schaap OL, Lansdorp PM (1987) Production of hybridoma growth factor by human monocytes. Eur J Immunol 17:1411-1416.
24. Kirnbauer R, Köck A, Schwarz T, Urbanski A, Krutmann J, Borth W, Damm D, Shipley G, Ansel JC, Luger TA (1989) IFN-β2, B cell differentiation factor 2, or hybridoma growth factor (IL-6) is expressed and released by human epidermal cells and epidermoid carcinoma cell lines. J Immunol 142:1922-1928.
25. Kishimoto T (1989) The biology of interleukin-6. Blood 74:1-10.
26. Feghali CA, Bost KL, Boulware DW, Levy LS (1992) Mechanisms of pathogenesis in scleroderma I. Overproduction of interleukin 6 by fibroblasts cultured from affected skin sites of patients with scleroderma. J Rheumatol 19:1207-1211.
27. Bucala R, Ritchlin C, Winchester R, Cerami A (1991) Constitutive production of inflammatory and mitogenic cytokines by rheumatoid synovial fibroblasts. J Exp Med 173:569-574.
28. Schmitter D, Lauber B, Ragg B, Stahel RA (1992) Hematopoietic growth factors secreted by seven human pleural mesothelioma cell lines: interleukin-6 production as a common feature. Int J Cancer 51:296-301.
29. Zhang Y, Lin J-X, Vilček J (1990) Interleukin-6 induction by tumor necrosis factor and interleukin-1 in human fibroblasts involves activation of a nuclear factor binding to a kB-like sequence. Mol Cell Biol 10:3818-3823.
30. Elias JA, Lentz V (1990) IL-1 and tumor necrosis factor synergistically stimulate fibroblast IL-6 production and stabilize IL-6 messenger RNA. J Immunol 145:161-166.
31. Ray A, Sassone-Corsi P, Seghal PB (1989) A multiple cytokine- and second messenger-responsive element in the enhancer of the human interleukin-6 gene: similarities with c-fos gene regulation. Mol Cell Biol 9:5537-5547.
32. Goodman L, Stein GH (1994) Basal and induced amounts of interleukin-6 mRNA decline progressively with age in human fibroblasts. J Biol Chem 269:19250-19255.
33. Cuba SC, Sartor Cl, Gottschalk LR, Ye-Hu J, Mulligan T, Emerson SG (1992) Bone marrow stromal fibroblasts secrete interleukin 6 and granulocyte-macrophage colony-stimulating factor in the absence of inflammatory stimulation: demonstration by serum-free bioassay, enzyme-linked immunosorbent assay, and reverse transcriptase polymerase chain reaction. Blood 80:1190-1198.
34. Rosenbaum JT, Cugnini R, Tara DC, Hefeneider S, Ansel JC (1992) Production and modulation of interleukin 6 synthesis by synoviocytes derived from patients with arthritic disease. Annal Rheum Dis 51:198-202.
35. Montz H, Koch KC, Zierz R, Gotze O (1991) The role of C5a in interleukin-6 production induced by lipopolysaccharide or interleukin-1. Immunology 74:373-379.
36. Maliszewski CR, Sato TA, Davison B, Jacobs CA, Finkelman FD, Fanslow WC (1994) In vivo biological effects of recombinant soluble interleukin-4 receptor. Proc Soc Exp Biol Med 206:233-237.
37. Hansen MB, Svenson M, Diamant M, Bendtzen K (1993) High-affinity IgG autoantibodies to IL-6 in sera of normal individuals are competitive inhibitors of IL-6 in vitro. Cytokine 5:72-80.
38. Shacter E, Arzadon GK, Williams JA (1993) Stimulation of interleukin-6 and prostaglandin E2 secretion from peritoneal macrophages by polymers of albumin. Blood 82:2853-2864.
39. Schillaci R, Eugui EM, Roldan A (1994) Insulin effect on interleukin 1 (IL-1) and interleukin 6 (IL-6) production by lipopolysaccharide-stimulated human monocytes. Horm Metab Res 26:113-115.
40. Espinoza LR, Aguilar JL, Espinoza CG, Cuéllar ML, Scopelitis E, Silveira LH (1994) Fibroblast function in psoriatic arthritis. I. Alteration of cell kinetics and growth factor responses. J Rheumatol 21:1502-1506.
41. Priestley GC, Adams LW (1985) Mitogenic effects of sera from normal and psoriatic subjects on human skin fibroblasts. Arch Dermatol Res 277:13-15.
42. Priestley GC, Adams LW (1983) Hyperactivity of fibroblasts cultured from psoriatic skin. II. Synthesis of macromolecules. Br J Dermatol 109:157-162.
43. Raynaud F, Evain-Brion D (1991) Protein kinase C activity in normal and psoriatic cells: cultures of fibroblasts and lymphocytes. Br J Dermatol 124:542-546.
44. MacLaughlin JA, Gange W, Taylor D, Smith E, Holick MF (1985) Cultured psoriatic fibroblasts from involved and uninvolved sites have a partial but not absolute resistance to the proliferation-inhibition activity of 1,25-dihydroxyvitamin D3. Proc Natl Acad Sci USA 82:5409-5412.
45. Yamato K, El-Hajjoui Z, Koeffler HP (1991) Expression of hematopoietic growth factor RNAs in human mesenchymal cells from various organs. Leukemia research 15:551-558.
46. Turksen K, Kupper TS, Degenstein L, Williams I, Fuchs E (1992) Interleukin 6: Insights to its function in skin by overexpression in transgenic mice. Proc Natl Acad Sci USA 89:5068-5072.
47. Sehgal PB (1990) Interleukin-6: molecular pathophysiology. J Invest Dermatol 94:2S-6S.
48. May LT, Helfgott DC, Seghal PB (1986) Anti-beta-interferon antibodies inhibit the increased expression of HLA-B7 mRNA in tumor necrosis factor-treated human fibroblasts: structural studies of the beta 2 Interferon involved. Proc Natl Acad Sci USA 83:8957-8961.
49. Srviastava MD, Deluca H, Ambrus JL (1994) Inhibition of IL-6 and IL-8 production in human fibroblast cell lines by 1,25 (OH)2 vitamin D3 and two of its analogs with lower calcemic activity. Res Commun Chem Pathol Pharmacol 83:145-150.
50. 3 is a potent regulator of interleukin-1 induced interleukin-8 expression and production. Biochem Biophys Res Com 176:1020-1026.
51. Hopkins SJ, Humphreys M (1989) Simple, sensitive and specific bioassay of interleukin 1. J Immunol Meth 120:271-276.
52. Espevik T, Nissen-Meyer J (1986) A highly sensitive cell line, WEHI 164 clone 13, for measuring cytotoxic factor/tumor necrosis factor from human monocytes. J Immunol Meth 95:99-105.
53. Mosmann TJ (1983) Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. J Immunol Meth 65:55-63.
54. Deleuran B, Iversen L, Kristensen M, Field M, Kragballe K, Thestrup-Pedersen K, Stengaard-Pedersen K (1994) Interleukin - 8 secretion and 15-lipoxygenase activity in rheumatoid arthritis: in vitro anti-inflammatory effects by interleukin-4 and interleukin-10, but not by interleukin-1 receptor antagonist protein. Br J Dermatol 33:520-525.
55. Ko Y, Mukaida N, Panyutich A, Voitenok NN, Matsushima K, Kawai T, Kasahara T (1992) Establishment of a sensitive enzyme-linked immunosorbent assay for human interleukin 8. J Immunol Method 149:227-235.
56. Chomczynski P, Sacchi N (1987) Single-step method of RNA isolation by acid guanidium thiocyanate-phenol-chloroform extraction. Anal Biochem 162:156-159.
57. Sambrook J, Fritsch EF, Maniatis T (1989) Molecular cloning: a laboratory manual. Cold Spring Harbor Laboratory Press, New York (second edition), pp 7.43-7.50 and 9.58.
58. Jeffreys AJ, Flavell RA (1977) A physical map of the DNA regions flanking the rabbit, β-globin gene. Cell 12:429-439.
59. Feinberg AP, Vogelstein B (1983) A technique for radio-labeling DNA restriction endonuclease fragments to high specific activity. Anal Biochem 132:6-13.
60. Brakenhoff JPJ, De Groot ER, Evers RF, Pannekoek H, Aarden LA (1987) Molecular cloning and expression of hybridoma growth factor in Escherichia coli. J Immunol 139:4116-4121.
61. Dixit VM, Green S, Sarma V, Holzman L, Wolf FW, O'Rouke K, Ward PA, Prochownik EV, Marks RM (1990) Tumor necrosis factor-α induction of novel gene products in human endothelial cells including a macrophage-specific chemotaxin. J Biol Chem 265:2973-2980.
62. Benham FJ, Hodgkinson S, Davies KE (1984) A glyceraldehyde-3-phosphate dehydrogenase pseudogene on the short arm of the human X chromosomes defines a multigene family. EMBO J 3:2635-2640.